Literature DB >> 10809518

Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity.

I Maremmani1, O Zolesi, M Aglietti, G Marini, A Tagliamonte, M Shinderman, S Maxwell.   

Abstract

We studied 90 opioid-dependent subjects, 38 with one or more additional Axis I diagnosis and 52 with no psychiatric comorbidity. There were significant differences between these two groups regarding the methadone dose required for clinical stabilization, but not in the rate of retention in treatment. Dual Diagnosis patients, those with psychiatric comorbidity, required an average stabilization dose of 154 +/- 84 of methadone compared to 99 +/- 49 mg/day for patients whose only Axis I diagnosis was Opioid Dependence. In the 990-day period considered there were no differences between the two groups of patients in terms of retention in treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809518     DOI: 10.1300/J069v19n02_03

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  14 in total

1.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

2.  Predictors of attrition from a national sample of methadone maintenance patients.

Authors:  Michael Mancino; Geoffrey Curran; Xiaotong Han; Elise Allee; Keith Humphreys; Brenda M Booth
Journal:  Am J Drug Alcohol Abuse       Date:  2010-05       Impact factor: 3.829

3.  The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?

Authors:  Icro Maremmani; Matteo Pacini; Pier Paolo Pani; Giulio Perugi; Joseph Deltito; Hagop Akiskal
Journal:  Ann Gen Psychiatry       Date:  2007-11-13       Impact factor: 3.455

4.  The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

5.  Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis.

Authors:  Michael J Mancino; Janette McGaugh; Zachary Feldman; James Poling; Alison Oliveto
Journal:  Am J Addict       Date:  2010 Mar-Apr

6.  Correlations between awareness of illness (insight) and history of addiction in heroin-addicted patients.

Authors:  Angelo Giovanni Icro Maremmani; Luca Rovai; Fabio Rugani; Matteo Pacini; Francesco Lamanna; Silvia Bacciardi; Giulio Perugi; Joseph Deltito; Liliana Dell'osso; Icro Maremmani
Journal:  Front Psychiatry       Date:  2012-07-09       Impact factor: 4.157

7.  Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?

Authors:  Angelo Giovanni Icro Maremmani; Luca Rovai; Pier Paolo Pani; Matteo Pacini; Francesco Lamanna; Fabio Rugani; Elisa Schiavi; Liliana Dell'osso; Icro Maremmani
Journal:  Ann Gen Psychiatry       Date:  2011-05-15       Impact factor: 3.455

8.  Determining effective methadone doses for individual opioid-dependent patients.

Authors:  Jodie A Trafton; Jared Minkel; Keith Humphreys
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

9.  QTc Prolongation in Veterans With Heroin Dependence on Methadone Maintenance Treatment.

Authors:  Sameer Hassamal; Antony Fernandez; Hossein Moradi Rekabdarkolaee; Ananda Pandurangi
Journal:  Int J High Risk Behav Addict       Date:  2015-06-20

10.  Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan.

Authors:  Hsin-Ya Lee; Jih-Heng Li; Yuh-Ling Sheu; Hsin-Pei Tang; Wei-Chiao Chang; Tze-Chun Tang; Yi-Chun Yeh; Shing-Yaw Wang; Ray-H Liu
Journal:  Biomed Res Int       Date:  2013-12-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.